To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Dr. Tarik Hadid specializes in treating patients with multiple cancers including lung cancer, head and neck cancer, thymic cancer, mesothelioma and esophageal cancers. He is an active member of the multidisciplinary teams in these areas. Dr. Hadid earned a Master of Science in Clinical Research Design and Statistical Analysis from the University of Michigan. He currently is an Associate Professor of Oncology at Wayne State University, School of Medicine. He participates in several clinical studies and has delivered numerous presentations and received awards at regional and national scientific meetings. Dr. Hadid has published several articles and abstracts. He actively participates in clinical and didactic education of fellows, residents and medical students.
Patient Power Research and clinical trials help lead to new treatments, especially targeted therapies. Now, patients with KRAS-mutated non-small cell lung cancer (NSCLC) have more options for treatment. Tarik Hadid, M.D., MPH, MS, FACP , medical oncologist and member of the Phase I Clinical Trials and Thoracic Oncology Multidisciplinary Teams at Karmanos, explained how KRAS inhibitors work for NSCLC patients who have the KRAS mutation. Read the article here .
Patient Power Taking medication is important when treating any type of disease, but we’re human – sometimes we may miss a dose. Tarik Hadid, M.D., MPH, MS, FACP , medical oncologist and member of the Phase I Clinical Trials and Thoracic Oncology Multidisciplinary Teams at Karmanos, offered tips to patients on what to do if they miss a dose and tactics to help them remember when to take their cancer medication. Read the article here .
Patient Power When going through lung cancer treatment, patients may learn that they must change their diet to assist with minimizing side effects and maintaining strength. Tarik Hadid, M.D., MPH, MS, FACP , medical oncologist and member of the Phase I Clinical Trials and Thoracic Oncology Multidisciplinary Teams at Karmanos, explained why lung cancer patients should consider working with a dietitian. Read the article here .